Therapeutic delivery of albumin-binding siRNA targeting IRS2 to diverse cell types reduces mammary tumor growth. - Tocheny CE; Buchwald JE; Dahlke CD; Fakih HH; Morgan JS; Summers A; Silva CA; Jackson SO; Lee JS; Card MA; Echeverria D; Peterson C; et al. (Molecular therapy : the journal of the American Society of Gene Therapy, 2026)